Endothelial cell dysfunction occurs after hemorrhage in nonheparinized but not in preheparinized models
Related Experiment Video
Updated: Nov 7, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
1Department of Surgery, Michigan State University, East Lansing 48824.
Although hemorrhage produces alterations in hemodynamics and cellular functions, it is not known whether endothelial cell function is depressed under such conditions and, if so, whether preheparinization has any protective effect on this function. To study this, rats (with or without heparinization prior to hemorrhage, 1 U/g body wt) were bled to and maintained at a mean arterial pressure of 40 mm Hg until 40% of maximal bleedout volume was returned in the form of lactated Ringer's solution (LR). The rats were then resuscitated with four times the volume of maximal bleedout in the form of LR. At 1.5 hr postresuscitation, the thoracic aorta was removed, cut into approximately 2.5-mm rings, and placed in organ chambers. Norepinephrine (2 x 10(-7) M) was applied to achieve near-maximal contraction, and dose responses for an endothelium-dependent vasodilator, acetylcholine, were determined. Hypoxia-induced contraction (an endothelium-dependent process) was also carried out using 95% N2:5% CO2. The results indicate that endothelium-dependent relaxation and contraction were markedly depressed following hemorrhage and resuscitation in nonheparinized, but not in preheparinized models. However, there was no significant difference in the relaxation induced by an endothelium-independent vasodilator, nitroglycerin, irrespective of heparinization. Thus, endothelial cell dysfunction (i.e., the depressed capacity of aortic endothelium to maximally release endothelium-derived relaxing and contracting factors) occurs after hemorrhage in nonheparinized, but not in preheparinized animals. Since trauma victims are not heparinized before the injury and since preheparinization protects endothelial cell function, pharmacologic agents to restore the depressed cellular function should be tested only in nonheparinized models of hemorrhage and resuscitation.
Although hemorrhage produces alterations in hemodynamics and cellular functions, it is not known whether endothelial cell function is depressed under such conditions and, if so, whether preheparinization has any protective effect on this function. To study this, rats (with or without heparinization prior to hemorrhage, 1 U/g body wt) were bled to and maintained at a mean arterial pressure of 40 mm Hg until 40% of maximal bleedout volume was returned in the form of lactated Ringer's solution (LR). The rats were then resuscitated with four times the volume of maximal bleedout in the form of LR. At 1.5 hr postresuscitation, the thoracic aorta was removed, cut into approximately 2.5-mm rings, and placed in organ chambers. Norepinephrine (2 x 10(-7) M) was applied to achieve near-maximal contraction, and dose responses for an endothelium-dependent vasodilator, acetylcholine, were determined. Hypoxia-induced contraction (an endothelium-dependent process) was also carried out using 95% N2:5% CO2. The results indicate that endothelium-dependent relaxation and contraction were markedly depressed following hemorrhage and resuscitation in nonheparinized, but not in preheparinized models. However, there was no significant difference in the relaxation induced by an endothelium-independent vasodilator, nitroglycerin, irrespective of heparinization. Thus, endothelial cell dysfunction (i.e., the depressed capacity of aortic endothelium to maximally release endothelium-derived relaxing and contracting factors) occurs after hemorrhage in nonheparinized, but not in preheparinized animals. Since trauma victims are not heparinized before the injury and since preheparinization protects endothelial cell function, pharmacologic agents to restore the depressed cellular function should be tested only in nonheparinized models of hemorrhage and resuscitation.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Vascular Spasm
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis I: Introduction
